Aleva Neurotherapeutics raised €3.3M in a Series B round in Apr 2012. The company is based in Lausanne, Switzerland. Investors in the round: Banexi Ventures. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €3.3M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
